Welcome to the Australasian Gastro-Intestinal Trials Group (AGITG) and the GI Cancer Institute.

We are a not-for-profit membership organisation dedicated to improving the health and quality of life of patients with Gastro-Intestinal (GI) cancer by developing and conducting collaborative multidisciplinary clinical trials. The AGITG membership encompasses a wide range of medical specialists, scientists, nurses, allied health professionals and consumers involved in all aspects of Gastro-Intestinal (GI) cancer research.

GI cancer includes the digestive organs: oesophagus, stomach, liver, gallbladder and biliary tract, pancreas, large and small bowel, rectum and anus.

The GI Cancer Institute and the AGITG work together to raise funds and awareness of GI cancer and clinical trials.



We understand many people in the GI cancer community may be feeling heightened concern about COVID-19. If you are worried about what COVID-19 means for you or your loved ones, please speak with your clinician or hospital, or access the following helpful resources:

  • Cancer Australia has a dedicated web section providing relevant, evidence-based COVID-19 information for people with cancer and health professionals.
  • Coronavirus Health Information Line – 1800 020 080. Call this number if you are seeking information on COVID-19.
  • Our resources section includes a support group directory, recommended reading and other helpful links.
  • A helpful patient video regarding treatment and support during this time.

Patient safety remains our top priority and our dedicated health professionals and trial staff are working to minimise potential risks and trial disruptions.